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Introduction
Evaluation of chronic aortopathies requires repeated fol-
low-up imaging studies to assess stability. MRI/MRA rou-
tinely has been used as the imaging modality of choice for
its multiple advantages over competing modalities. How-
ever, recently there is heightened concern over gadolin-
ium-enhanced MRA in patients with significant renal
insufficiency as a result of nephrogenic systemic fibrosis
(NSF). Development of a robust non-gadolinium
enhanced MRI/MRA technique is needed for evaluation of
aortopathies, particularly in patients with renal insuffi-
ciency.
Purpose
A robust 3D SSFP non-gadolinium enhanced MRA tech-
nique is equivalent or superior to traditional 3D gadolin-
ium enhanced MRA.
Methods
We prospectively evaluated 26 consecutive patients (21
men, 5 women; mean age 51 years) referred for evaluation
of aortopathies, all of whom had normal renal function.
Patients were referred for evaluation of aneurysms (n =
18), dissection (n = 2), graft integrity (n = 2), and coarcta-
tion (n = 4). All patients underwent MRI on a 1.5 Tesla
scanner (Avanto, Siemens Medical Solutions), which
included both 3D gadolinium-enhanced (Gad) and non-
gadolinium enhanced (nonGad) MRA of the aorta. Non-
Gad MRA images were acquired in a sagittal orientation
using an ECG-triggered, fat saturated, T2-prepared, seg-
mented 3D SSFP technique. Gad MRA images were
acquired using a non-triggered acquisition which is the
standard at our institution, following 20 cc gadolinium-
DTPA injection (Magnevist, Schering). The matrix size was
similar for both techniques (1.4 × 1.4 × 1.5 mm3). Each
MRA sequence covered the proximal aortic arch branch
vessels down to the level of renal arteries. Two physicians
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Table 1: Qualitative assessment scores for 3D MRA techniques.
Non-Gadolinium Enhanced MRA Gadolinium Enhanced MRA
Aortic Root 4.5 1.9
Ascending Aorta 4.1 3.2
Aortic Arch 4.4 4.5
Descending Thoracic Aorta 4.9 4.8
Abdominal Aorta 4.4 4.8
Time (Minutes, Overall) 10.8 5.8
Time (Minutes, Last 15 Studies) 5.8 5.8Page 1 of 3
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quantitative and qualitative analysis at five pre-deter-
mined anatomic locations (aortic root, mid ascending
thoracic aorta, aortic arch, proximal descending thoracic
aorta, and diaphragmatic hiatus) for both MRA tech-
niques. For qualitative analysis, a point scale (1 to 5, 1 =
nondiagnostic/uninterpretable, 5 = diagnostic quality/no
artifacts) was used for presence or absence of artifacts that
limit confidence in formulating the diagnosis or making
measurements at predetermined anatomic locations. A
sub-analysis was performed on patients with prior
median sternotomies (n = 7). Table 1.
Results
There was no significant inter-observer variability for the
quantitative and qualitative analyses of the MRI/MRAs.
For both physicians, the qualitative point scores of the
aortic root and ascending thoracic aorta were consistently
higher for the nonGad technique compared to the gad
MRA (p < 0.01). Even for patients with prior median ster-
notomy, the difference remained statistically significant in
favor of nonGad MRA (p < 0.05). There was no significant
difference between the two MRA techniques for evalua-
tion of the aortic arch, descending thoracic aorta, and
abdominal aorta. The mean total scan time was 10.8 min-
utes for nonGad MRA and 5.8 minutes for Gad MRA. Fig-
ures 1 and 2.
Conclusion
Non-gadolinium enhanced MRA allows for comprehen-
sive evaluation of aortopathies with a single sequence.
Compared to Gad MRA, nonGad MRA is an equivalent
technique for quantitative measurement and a superior
technique for qualitative evaluation of the aortic root and
ascending thoracic aorta. Thorough and accurate evalua-
tions of the aortic root and ascending thoracic aorta
(extent of dissection, involvement of coronary arteries,
and aortic valve leaflets) are critical and affect clinical
management (surgical vs medical intervention). Qualita-
tive evaluation was particularly improved for the aortic
root and ascending segment as a result of ECG-gating
inherent within the nonGad sequence minimizing
motion artifacts to which gadolinium-enhanced images
were prone. Theoretically, sternal wires pose problems
due to susceptibility artifacts; however, our study results
indicate the superiority of nonGad MRA technique even
in patients with sternal wires. The 3D nonGad sequence
alleviates concerns about NSF and may be a preferred
sequence for patients with renal insufficiency and clinical
concern for aortopathies. In summary, 3D non-gadolin-
Figure 2
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ium enhanced MRA is a robust technique that provides
equivalent or superior information on aortopathies com-
pared to standard gadolinium enhanced MRA.Page 3 of 3
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